Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4765765

O=C(Nc1ccc2c(c1)CCN(C1CCC1)CC2)c1ccccc1C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 3/20 0.50
LMNA P02545 1/20 0.50
PTGES O14684 6/20 0.48
NPC1 O15118 4/20 0.47
RAB9A P51151 3/20 0.47
NFKB1 P19838 2/20 0.47
HTT P42858 2/20 0.47
NFKB2 Q00653 2/20 0.47
RELA Q04206 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
MAPT P10636 1/20 0.47
PTGS1 P23219 1/20 0.47
KCNK3 O14649 1/20 0.47
KCNK9 Q9NPC2 1/20 0.47
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
ATM Q13315 1/20 0.46
PTPRC P08575 1/20 0.45
SLC2A1 P11166 1/20 0.44
RXFP1 Q9HBX9 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4772451 0.96 TP53 (0.53) TP53LMNAPTGESNPC1RAB9A
Trifluoroacetic Acid SCHEMBL4765546 0.88 MEN1 (0.53) TP53NPC1RAB9ANFKB1HTT
Trifluoroacetic Acid SCHEMBL4774158 0.87 TMPRSS2 (0.55) TP53NPC1RAB9ANFKB1HTT
Trifluoroacetic Acid SCHEMBL4770456 0.86 NPC1 (0.52) TP53NPC1RAB9ANFKB1HTT
Trifluoroacetic Acid SCHEMBL4770314 0.85 HRH3 (0.52) TP53NPC1RAB9ANFKB1HTT
Trifluoroacetic Acid SCHEMBL4774281 0.83 SLC2A1 (0.58) TP53NPC1RAB9ANFKB1HTT
SCHEMBL4768342 0.83 HRH3 (0.45) TP53LMNAPTGESNPC1RAB9A
Trifluoroacetic Acid SCHEMBL4765223 0.83 MEN1 (0.44) TP53LMNANPC1RAB9ANFKB1
Trifluoroacetic Acid SCHEMBL4768284 0.83 HRH3 (0.46) TP53NPC1RAB9ANFKB1HTT
Trifluoroacetic Acid SCHEMBL4772070 0.82 KMT2A (0.50) TP53LMNANPC1RAB9AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1713778-B1 BENZAZEPINE DERIVATIVES AS HISTAMINE H3 ANTAGONISTS GLAXO GROUP LTD (GB) 2008-01-16 EP claimed
US-20070060566-A1 Benzazepine derivatives as histamine h3 antagonists GLAXO GROUP LIMITED (GB) 2007-03-15 US claimed
EP-1713778-B1 BENZAZEPINE DERIVATIVES AS HISTAMINE H3 ANTAGONISTS GLAXO GROUP LTD (GB) 2008-01-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060566-A1 Benzazepine derivatives as histamine h3 antagonists HRH3, HRH4, HRH1 TP53 4863/4885LMNA 3210/4885PTGES 2607/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.